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Abstract
Background: Pneumococcal β-lactam resistance was first detected in Iceland in the late 1980s, and subsequently
peaked at almost 25% of clinical isolates in the mid-1990s largely due to the spread of the internationally-disseminated
multidrug-resistant PMEN2 (or Spain
6B-2) clone of Streptococcus pneumoniae.
Results: Whole genome sequencing of an international collection of 189 isolates estimated that PMEN2 emerged around
the late 1960s, developing resistance through multiple homologous recombinations and the acquisition of a Tn5253-type
integrative and conjugative element (ICE). Two distinct clades entered Iceland in the 1980s, one of which had acquired a
macrolide resistance cassette and was estimated to have risen sharply in its prevalence by coalescent analysis.
Transmission within the island appeared to mainly emanate from Reykjavík and the Southern Peninsular, with evolution
of the bacteria effectively clonal, mainly due to a prophage disrupting a gene necessary for genetic transformation in
many isolates. A subsequent decline in PMEN2’s prevalence in Iceland coincided with a nationwide campaign that
reduced dispensing of antibiotics to children in an attempt to limit its spread. Specific mutations causing inactivation
or loss of ICE-borne resistance genes were identified from the genome sequences of isolates that reverted to drug
susceptible phenotypes around this time. Phylogenetic analysis revealed some of these occurred on multiple occasions
in parallel, suggesting they may have been at least temporarily advantageous. However, alteration of ‘core’ sequences
associated with resistance was precluded by the absence of any substantial homologous recombination events.
Conclusions: PMEN2’s clonal evolution was successful over the short-term in a limited geographical region, but its
inability to alter major antigens or ‘core’ gene sequences associated with resistance may have prevented persistence
over longer timespans.
Keywords: Bacterial evolution, Antibiotic resistance, Recombination, Mobile genetic elements, Coalescent analysis,
Phylogeography
Background
Despite the high frequency of horizontal sequence transfer
in the pneumococcal population, the spread of multidrug-
resistant (MDR) Streptococcus pneumoniae has primarily
reflected the global dissemination of particular clones ra-
ther than the acquisition of resistance by resident, sensitive
genotypes [1]. MDR pneumococci were first identified in
1977 [2], with the phenotype becoming very common in
some countries during the 1980s due to the spread of
several MDR clones [3,4]. However, the absence of such
bacteria from Iceland meant no penicillin resistance
was detected among S. pneumoniae on the island until
December 1988 [5]. This was in spite of the country
having the highest per capita consumption of antibiotics of
t h eN o r d i cc o u n t r i e sa tt h et i m e[ 6 ] .
Levels of resistance subsequently rose to a peak in 1995,
by which point 24.2% of Icelandic clinical pneumococcal
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of these were of serotype 6B and also exhibited resistance
to co-trimoxazole, chloramphenicol, tetracycline and
macrolides [6,7,9]. Genotyping demonstrated that the
pneumococci sharing these characteristics were a clonal
outbreak closely related to isolates found in Spain in the
late 1980s, defined as the Spain
6B-2 or PMEN2 lineage [10],
suggesting a transmission from Western Europe [6].
Consequently, an effort was initiated to reduce consump-
tion of antibiotics [11] that achieved a 35% fall in dispensing
to Icelandic children between 1992 and 1997 [12]. The
prevalence of PMEN2 fell over subsequent years but despite
these alterations in clinical p r a c t i c ea n dt h ep r e s e n c eo f
other MDR genotypes [7], serotype 6B pneumococci still
constituted around 3% of Icelandic penicillin non-
susceptible clinical isolates in 2010 [8]. The genotype was
found to be variably prevalent in different communities,
disappearing from some but persisting in others in a man-
ner that was suggested to relate to local antibiotic prescrib-
ing rates and herd immunity [13]. Furthermore, some
PMEN2 representatives with losses of particular resistances
were identified, which may have been a sign of adaptation
to reduced antibiotic consumption [9]. In the case of tetra-
cycline and macrolides, reversions to susceptibility ap-
peared to have occurred through more than one type of
mutation, as they were associated with both the presence
and absence of the associated resistance gene.
As well as being found throughout Western Europe from
the 1980s onwards [6,14-17], the PMEN2 lineage has also
been detected in the United States [18-21], South America
[22,23], the Middle East [24], South-East Asia [25-27],
Australia [28] and Japan [29]. Multilocus sequence typing
(MLST) generally finds such isolates to be of, or similar to,
sequence type (ST) 90. This suggests it is closely related to
the PMEN22 lineage, first identified in countries around
the Mediterranean [30,31] and subsequently found in
Western Europe and the United States [32,33]. The
PMEN22 genotype is associated with ST273, which differs
from ST90 at only two of the seven MLST loci, and gener-
ally has a similar resistance profile to PMEN2 with the ex-
ception that representatives are typically β-lactam
susceptible. An international collection of 189 isolates was,
therefore, assembled to identify the relationship between
these two lineages and trace the emergence and spread of
the PMEN2 clone. This included 118 isolates from Iceland
to reconstruct the outbreak on this island in detail, and
thereby characterise its initial success and subsequent
population dynamics in response to altered antibiotic dis-
pensing practices.
Results
Multiple resistance elements across a diverse collection
A total of 189 isolates from twelve countries that
spanned the period from 1988 to 2009 were sequenced
as multiplexed libraries using the Illumina platform [see
Additional file 1: Table S1]. Reads were mapped against
the reference genome of S. pneumoniae 670-6B and
bases called using previously-defined criteria [34], lead-
ing to the identification of 36,038 polymorphic sites.
Reconstructing the evolutionary history of the lineage as
described previously [35] suggested that 63,053 base
substitutions, primarily the result of 616 recombina-
tions, had occurred during the divergence of the isolates
in the collection (Figure 1). Analysis with an alternative
algorithm for detecting recombination produced similar
results [see Additional file 2: Figure S1]. The recon-
struction involved 3,955 point mutations, giving an esti-
mate of the overall per site r/m (the ratio of base
substitutions introduced by recombination relative to
point mutations) of 14.9; this compares with a typical
range from around 0.1 to more than 30 for common
pneumococcal lineages [36,37]. However, it is clear that
many of these events occurred within putative mobile gen-
etic elements (MGEs) and were, therefore, unlikely to be
the products of genetic transformation, but rather seemed
to primarily represent the consequences of phage move-
ment. Excluding the 242 recombinations within MGEs re-
duced the r/m due to homologous recombination to 9.80.
This subset of recombinations had a mean length of 8.8 kb
and followed an approximately exponential length distribu-
tion [see Additional file 3: Figure S2] [38], with each event
importing a mean of 104 base substitutions. The import of
sequence via transformation appears to have happened
most frequently at the penicillin-binding protein genes
pbp2x (just upstream of the capsule polysaccharide synthe-
sis, or cps,l o c u s )a n dpbp2b, which are important in deter-
mining resistance to β-lactams, as well as around the pspC
gene, which encodes the Pneumococcal Surface Protein C
antigen [39]. No putative recombinations were found to
affect the cps locus, the gene cluster that determines an
isolate’s serotype. However, this did not preclude a switch
from serotype 6B to 6A occurring in isolate 1014–00
through the A584G base substitution in wciP causing an
N195S amino acid change in the corresponding rhamnosyl
transferase enzyme, a polymorphism previously associated
with determining which of these two polysaccharide types
an isolate produces [40]. Only one other base substitution,
a non-synonymous change within the regulatory gene wze,
occurred within the cps locus on the same branch of the
phylogeny, suggesting this alteration could have occurred
either through recombinations importing limited diversity
or through point mutations.
The resultant phylogeny robustly separated the PMEN2
and PMEN22 clones from a third, distinct clade [see
Additional file 4: Figure S3]. All three groups showed
evidence of having acquired Tn5253-type integrative
and conjugative elements (ICE; Figure 2). These are large
composite elements in which a Tn916-type element
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inserted into a larger Tn5252-type element [41,42]. The
oldest and most diverse clade, labeled ‘Outgroup’ in
Figure 1, was composed of isolates that were universally
β-lactam sensitive. The ICE within this Outgroup clade
could be represented by four archetypes, which exhibited
similarity in gene content but a large degree of structural
variation, such as inversion of Tn916-type components,
differences in the length of the Tn5252-type element and
variation in the presence of different macrolide resistance
cassettes within the Tn916-type element (Figure 2 and
Additional file 5: Figure S4) [35]. This made it difficult to
deduce whether these represent the entry of a single
element that has been maintained (albeit with in situ
modification) across the clade, or multiple acquisitions of
related ICE.
A second clade corresponded to the PMEN22 lineage
(Figure 1). This clade had a relatively high r/m: 18.84
overall and 13.73 excluding recombinations within
MGEs. These isolates all inherited the insertion of a
single, novel large Tn5253-type ICE, consequently
named ICESp6BST273 (Figure 2 and Additional file 6:
Figure S5). Macrolide resistance across the clade was
mainly the result of a Tn917 cassette [43] within the
ICE carrying a ribosomal RNA methylase gene (ermB).
Chloramphenicol resistance was the result of a cat
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Figure 1 Phylogenomic analysis of the sequenced isolates. (A) Maximum likelihood phylogeny of the isolates based on likely point mutations.
The branches of the phylogeny are coloured according to the geographical location of the isolates, as reconstructed through the tree on the basis
of maximum parsimony. The PMEN2 and PMEN22 clades are indicated by the black vertical bars; the grey shaded box marks the ‘Outgroup’ clade.
Isolates from Iceland are indicated by the orange boxes highlighting clades IC1 and IC2. Isolates from Spain previously providing evidence of
transmission from continental Europe are marked with single asterisks; the German isolate most closely related to clade IC1 is marked with a double
asterisk. The PMEN22 isolate that has become resistant to β-lactams is marked by the † symbol. (B) Simplified annotation of the reference genome
against which sequence reads were mapped. The positions of putative mobile genetic elements (MGEs) is marked, along with the capsule polysaccharide
synthesis locus (cps), Pneumococcal Pathogenicity Island 1 (PPI-1), the gene for penicillin-binding protein 2B (pbp2b), and the antigen-encoding genes
pspA and pspC. (C) Density of recombination events across the genome: (i) across the entire collection, (ii) within only the PMEN2 clade. (D) Distribution of
recombination events. The dashed line defines a panel consisting of a row for each of the sequenced isolates in the collection, with a column for each
base in the reference sequence. Putative recombination events are indicated by the coloured blocks: red events are reconstructed as occurring on internal
branches and are, therefore, shared by multiple isolates through common descent, whereas blue blocks are recombinations occurring on terminal
branches, which are unique to individual isolates.
Croucher et al. BMC Biology 2014, 12:49 Page 3 of 15
http://www.biomedcentral.com/1741-7007/12/49chloramphenicol acetyltransferase within a pC194-type
sequence [44] as part of a gene cluster very similar to
the Ωcat(pC194) element found within Tn5253 [45] [see
Additional file 6: Figure S5]. De novo assemblies indicated
this sequence could transpose to different loci within the
genome, sometimes integrated into the ICE or Pneumo-
coccal Pathogenicity Island-1, as was observed for the
archetypal element [45]. This represents a further ex-
ample of sequence exchange between ICE and this is-
land [42,46]. The PMEN22 clade was generally β-lactam
sensitive, except for a single resistant isolate (SN33007) that
was predicted to have imported 23 segments of sequence,
totaling just under 254 kb in length, that affected the peni-
cillin binding protein genes pbp1a, pbp2x and pbp2b,b u t
not pbp2a or murMN.
Diversification and dissemination of PMEN2
β-lactam resistance was independently acquired by the lar-
gest clade, corresponding to PMEN2, all isolates of which
were distinguished from the Outgroup and PMEN22 clades
by 17 shared segments of recombinant sequence that to-
taled 156 kb in length. This resulted in the import of
resistance-associated alleles of pbp1a, pbp2x and pbp2b
[47], but no contemporaneous recombinations affecting
pbp2a or murMN were detected. Resistance to tetracycline
and chloramphenicol resulted from the acquisition of
ICESp6BST90 on the same branch of the phylogeny, which
was shared by all PMEN2 representatives through common
descent [see Additional file 6: Figure S5]; this contained
both a Tn916-type element and a Ωcat(pC194)-like elem-
ent [44,45] [see Additional file 7: Figure S6]. Therefore, the
antibiotic resistance determinants of PMEN2 and PMEN22
appear to have been entirely independently acquired. Many
isolates were also resistant to macrolides owing to the ac-
quisition of the ermB gene carried on either the Omega
cassette [35] or Tn917, both of which appear to have been
acquired more than once during the evolution of PMEN2
[see Additional file 5: Figure S4]. Based on one atypical
Tn916-type sequence [see Additional file 8: Figure S7], it
seems likely that both cassettes were acquired by a recent
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Figure 2 Comparison of integrative and conjugative elements (ICE) identified in the collection. Eight examples of composite Tn5253-type
ICE found in the collection are aligned: ICESp6BST273, found in PMEN22, ICESp6BST90, found in PMEN2 (examples modified by the integration
of macrolide resistance cassettes are included), and four ICE representing the diversity found in the outgroup. Red bands indicate BLAT matches
between sequences in the same orientation and blue twisted bands indicate BLAT matches between sequences in opposite orientations. In both
cases, the intensity of the colour indicates the strength of the match. Protein coding sequences (CDSs) are indicated by pink boxes, except those
encoding antibiotic resistance determinants, which are coloured dark blue. The vertical position above or below the central line indicates whether the CDS
is encoded on the forward or reverse strand of the sequence. The tetM tetracycline resistance gene, found within the Tn916-type elements, is marked at
the top and bottom of the alignment. The ermB macrolide resistance gene is found within Tn917 cassettes (boxed in purple throughout the alignment)
or Omega cassettes (boxed in green throughout the alignment). The cat chloramphenicol acetyltransferase is carried on the linearized pC194 plasmid,
indicated by blue boxes on the annotation. BLAT, BLAST-like alignment tool.
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thereby arranging two highly similar ermB genes in tandem.
A subsequent intragenomic recombination between them
appears to have deleted the intervening sequence, resulting
in a reversion to tetracycline susceptibility owing to the loss
of the tetM gene, but leaving the aminoglycoside resistance
gene aph3’ and ermB in its place.
A plot of the root-to-tip distance of the isolates within
the PMEN2 clade relative to their date of isolation re-
vealed a significant linear correlation (n=168,R
2=0.63,
P value <2.2 × 10
−16) that suggested a date of origin
around 1967 [see Additional file 9: Figure S8A]. A
Bayesian coalescent analysis of the clade estimated the
most likely date of origin to be 1969 (95% credibility
interval, 1962 to 1974), implying a point mutation rate
of 1.11 × 10
−6 substitutions per site per year (95% cred-
ibility interval of 9.82 × 10
−7 to 1.24 × 10
−6 substitutions
per site per year). This origin is likely to have occurred
in Western Europe (Figure 1), in accordance with the
site of the first identification of the clone [17]. PMEN2
then seems to have spread to other continents on mul-
tiple occasions, concurrent with isolates undergoing ex-
tensive diversification across much of the genome.
Clonal evolution within Iceland
By contrast, the Icelandic isolates formed two clades
(IC1 and IC2), neither of which exhibited strong evi-
dence of having engaged in homologous recombination
(Figure 1). Clade IC2 appears to represent a relatively
unsuccessful transmission to the island; all six represen-
tatives were macrolide sensitive, as they carried versions
of ICESp6BST90 lacking an ermB-containing cassette.
The most recent common ancestor of IC2 was estimated
to have existed around 1984 (95% credibility interval,
1980 to 1987) shortly before the first clinical isolate was
detected, but no isolates belonging to the clade were
detected from 1994 onwards. The IC2 isolates corre-
sponded to three similar pulsed field gel electrophoresis
(PFGE) patterns [9]; although no putative homologous
recombinations were identified within this group that
might have caused such diversification, there were five
recombination events within MGEs indicating that the
acquisition of autonomously mobile elements may have
caused the alterations. The larger IC1 clade was com-
posed of 112 isolates and appears to have entered
Iceland at a similar time, around 1986 (95% credibility
interval, 1985 to 1987). These isolates were generally
macrolide resistant due to the insertion of Tn917 into
ICESp6BST90 (Figure 2).
Only 20 recombinations were detected within clade
IC1, of which 14 occurred within prophage and appear
to represent the movement of viral sequences. Each of
the remaining six events imported no more than eight
substitutions, far below the mean of 104 substitutions
per recombination in the wider collection. Consequently,
all of the isolates tested near the start of the outbreak
corresponded to a single PFGE type [9], and the clade’s
r/m was 0.18, falling to 0.024 when recombinations
within MGEs were excluded. This seems largely due to
the insertion of a prophage, henceforth referred to as
ΦIC1, into the comYC (also known as comGC) gene,
which encodes a component of the competence pilus es-
sential for the uptake of exogenous DNA into the cell
[48]. The integration of prophage into this locus has pre-
viously been experimentally associated with the loss of
competence for transformation [35]. Sequence read
mapping to ΦIC1 revealed that related viruses with very
similar integrases, which seem to target the same locus
based on cases where the prophage could be assembled
de novo, appear to have inserted into PMEN2 repre-
sentatives across the world on several occasions [see
Additional file 10: Figure S9 and Additional file 11:
Figure S10]. This analysis of prophage distribution also
showed that the ΦIC1 virus is absent from the chromo-
somes of many isolates within clade IC1, indicative of fre-
quent loss. Based on de novo assemblies, the comYC gene
seems to have returned to a functional form in these sam-
ples, demonstrating that the MGE’s excision is precise.
However, loss of the prophage was not associated with a
detectably elevated rate of sequence import, as only one of
the putative homologous recombination events was asso-
ciated with isolates carrying ‘repaired’comYC genes.
Phylodynamics of the Icelandic outbreak
The phylogeny supported the hypothesis that PMEN2
entered Iceland from Western Europe [6] (Figure 1 and
Additional file 4: Figure S3), but not the suggestion of
Spain in particular being the source, which was based on
genotyping of isolates SP522 and SP681 (Figure 1). The
isolate most closely related to clade IC1 was from
Germany, albeit from 1998, post-dating the estimated
dates of clades IC1 and IC2 arriving in Iceland by
around a decade. The transmission and population dy-
namics of clade IC1 subsequent to its entry into Iceland
were reconstructed using a coalescent model to combine
the sequence alignment with the detailed epidemio-
logical information available. This analysis could be per-
formed independently of the rest of the collection, as
this clade alone showed a significant correlation be-
tween root-to-tip distance within the clade and day of
isolation (n =112, R
2 =0.56 ,P value <2.2 × 10
−16;A d d -
itional file 9: Figure S8B). This estimated the date of IC1’s
common ancestor as around October 1987 (95% confi-
dence interval September 1986 to August 1988), consist-
ent with the overall analysis of the PMEN2 clade.
The change in the clade’s prevalence was estimated
using a Bayesian skyline plot (Figure 3) [49]. This traces
changes in the product of the effective population size (Ne)
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plot can be taken as an estimate of Ne over time. This ana-
lysis found Ne to start at zero when the genotype entered
the country, rising to a peak in the mid-1990s, before drop-
ping to a much lower level by 2004. Comparison with the
recorded numbers of penicillin non-susceptible serogroup
A
B
C
Figure 3 Temporal dynamics of clade IC1 in Iceland. (A) Bayesian skyline plot of the product of effective population size and generation
time over the course of the outbreak. The median estimate of this parameter is displayed as the black line, while the 95% credibility interval is
indicated by the blue filled area. The solid red line indicates the recorded numbers of penicillin non-susceptible pneumococci of serotype 6B
collected from cases of disease in Iceland between 1989 and 1995. The dashed red line indicates the available figures for the number of clinical
isolates meeting these criteria collected from the Capital and Southwestern areas from 1995 onwards, which account for more than 90% of the
penicillin non-susceptible pneumococci identified in Iceland [8]. (B) Proportion of clade IC1 isolates resistant to tetracycline, erythromycin and
chloramphenicol over time. The total number of sequenced isolates from clade IC1 is represented by the black line, relative to the right side
vertical axis. The proportions of these isolates resistant to selected antibiotics in each year, excluding those for which no phenotype was available
or that were defined as having an ‘intermediate’ resistance phenotype [see Additional file 1: Table S1], are represented by the coloured lines
relative to the left side vertical axis. (C) Use of antibiotics in Iceland. Annual defined daily doses (DDD) in Iceland for classes of antibiotics against
which IC1 isolates were found to have resistance are displayed. The data in panels (B) and (C) are plotted using the midpoint of each year such
that they are displayed on approximately the same timescale as the changes in the effective population size of IC1 in panel (A).
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vealed a similar pattern of rise and fall. There was not a
clear relationship with the overall levels of usage of any one
particular antibiotic over time, although post-1995 there
was a consistent fall in the usage of penicillins, sulphona-
mides and macrolides. However, these chart the overall
consumption of antibiotics, whereas the reduction in pre-
scribing was targeted at children (the primary hosts for the
pneumococcus), in whom consumption fell by 35% [12].
Furthermore, it may well be that these overall trends masked
more obvious changes at the level of individual communities,
as seen by location-specific epidemiological surveillance [13].
To trace transmission at a more local level, a discrete
state phylogeographic model was fitted as part of the
coalescent analysis (Figure 4). This analysis indicated
Reykjavík was an important source of transmissions, be-
ing the reconstructed location of more than 90% of the
phylogeny’s internal nodes, including the root node.
However, this might have been anticipated from the
composition of the collection, given that 81% of the IC1
isolates were from the capital and surrounding suburbs,
which contained around 57% of the total Icelandic popu-
lation at the start of the outbreak [6]. Correspondingly,
randomly permuting the locations of the isolates 100
times found the same, or greater, proportion of internal
nodes to be ascribed to Reykjavík in 88 cases, with every
permutation attributing the root node as emanating
from the capital. By contrast, the second most common
location of Reykjanesbær was associated with five in-
ternal nodes in the original analysis; a similar pattern
was only reconstructed in a single permutation. Hence,
the phylogeographic analysis provided significant evi-
dence of a series of transmissions across the relatively
densely populated southern peninsular of the island,
distinct from the network of transmissions involving
Reykjavík.
‘Disarming’ of an MDR clone
All isolates prior to 1992 for which definitive phenotypes
were available were resistant to tetracycline, macrolides
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Figure 4 Transmission of clade IC1 within Iceland. (A) A phylodynamic analysis was conducted to reconstruct the transmission of the IC1
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six defined in [9] based on resistance phenotype and genotype, which are described in the main text.
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Figure 3B]; however, after the reduction in antibiotic dis-
pensing, isolates that appeared to have reverted to a sus-
ceptible phenotype were observed. Based on isolates’
resistance profile and the presence of the tetM and ermB
genes, six groups were identified (Figure 4). Group 1 iso-
lates had the resistance profile expected from the ori-
ginal genotype, whereas deviations were classed in
groups 2 to 6 [9]. Group 2 isolates were tetracycline sen-
sitive, despite a DNA probe indicating that the tetM
gene was present. Five examples were evident in this
collection, distributed polyphyletically as one clade of
three isolates and two singletons. In each case, the alter-
ation in phenotype was associated with the same 58 bp
deletion upstream of tetM (Figure 5). Normally, tetM
transcription is thought to be repressed through an at-
tenuation mechanism: the rapid initiation of translation
of a leader peptide results in the formation of a hairpin
loop that terminates RNA synthesis before the resistance
determinant is transcribed [50]. However, in the pres-
ence of tetracycline, the translation of the leader peptide
is delayed enough that a different set of stem-loops
form, resulting in the expression of the tetM coding se-
quence. Therefore, it seems likely that the 58 bp deletion
disrupted this mechanism and thereby constitutively
inhibited the synthesis of the TetM protein. This muta-
tion was not observed in any non-Icelandic isolates.
Group 3 isolates were again tetracycline sensitive, but
differed in also being susceptible to macrolides, having
apparently lost both the tetM and ermB genes. This
phenotype appears to have emerged twice within clade
IC1; in both cases, it was associated with the excision of
the Tn916-type element. This loss was evident both
from comparison of de novo assemblies with the refer-
ence, as well as an absence of sequence read mapping to
the element (Figure 5). The removal of the ICE was pre-
cise and led to the restoration of a gene encoding a zinc-
dependent peptidase that appeared to have been split by
the insertion of the Tn916-type component in the for-
mation of the composite ICE. Aside from the deletion
within Tn916 driven by the tandem ermB genes, this
element was stable across the rest of the PMEN2 clade,
as observed in other lineages [35].
Group 4 isolates were tetracycline resistant but macro-
lide sensitive, despite retaining the ermB gene and, by
implication, the Tn916-type element. This phenotype
was found in a single clade of three isolates within IC1.
De novo assembly revealed this to be the consequence of
8 bp of the ermB CDS being replaced by 7 bp of divergent
sequence, introducing a frameshift mutation that trun-
cated the resistance gene. The disruptive 7 bp sequence
is an inverted copy of the same pattern of bases found
downstream within ermB, suggesting that the change
may have been driven by an unusual intragenomic
recombination. This mutation only appears to have oc-
curred once across the entire collection.
Group 5 isolates were defined as those displaying sus-
ceptibility to chloramphenicol; however, it was not previ-
ously possible to determine whether this was correlated
with the loss of the cat chloramphenicol acetyltransfer-
ase gene. Analysis of the de novo genome assemblies re-
vealed that the frequent emergence of this phenotype in
the collection was, once more, associated with isolates
both possessing, and having lost, the ICE-encoded gene.
One clade of isolates had a 9.36 kb deletion within the
Tn5252-type component of the ICE that eliminated part
of the Ωcat(pC194)-like element, including the cat gene;
this appears to have resulted from an intragenomic recom-
bination between the long tandemly-repeated sequences on
either side (Figure 5D). This unstable element also appears
to have been lost outside of Iceland on several occasions
[see Additional file 6: Figure S5]. However, no obvious can-
didate mutations causing chloramphenicol susceptibility
could be found affecting the Ωcat(pC194)-like element in
other group 5 representatives, although ambiguities in es-
tablishing the element’s mobility and insertion site made it
difficult to fully characterize in all isolates. Group 6 isolates,
susceptible to chloramphenicol, tetracycline and macrolides
despite retaining the required genes, similarly lacked any
obvious mutation underlying their resistance profile.
Discussion
The PMEN2 lineage appears to have emerged in the late
1960s, around the same time as PMEN1 (Spain
23F-1),
when β-lactam non-susceptible pneumococci were first
being detected [51]. Therefore, PMEN2 is likely to have
been one of the first such genotypes. Both PMEN1 and
PMEN2 seem to have acquired near-identical penicillin-
binding protein sequences, and both acquired cat from
pC194, and tetM from Tn916, as part of a Tn5253-type
element [42,47]. While PMEN1 was more successful in
many countries, it was PMEN2 that predominated in
Iceland, despite the presence of other MDR clones
(PMEN1 among them) [7]. More specifically, clade IC1
of PMEN2 appears to have been much more successful
than IC2, which may reflect the macrolide resistance
cassette carried by clade IC1. This is supported by the
observation that treatment with erythromycin was asso-
ciated with double the risk of carrying penicillin resistant
pneumococci as treatment with β-lactams in Iceland at
the time [52].
The fall in dispensing of antibiotics to children that
started in 1992 is likely to have reduced the selection
pressure driving PMEN2’s success within Iceland [53]. In
the mid-1990s, this seems to be reflected in the in-
stances of the MDR clone being ‘disarmed’. Each of the
reversions to chloramphenicol, tetracycline and macro-
lide sensitivity occurred both in the presence and
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some of the specific mutations were homoplasic within
clade IC1. Such convergent evolution is likely driven by
selection; this would suggest that these resistance mech-
anisms impose a fitness cost upon the host cell and,
therefore, tend to degrade as they became less advanta-
geous [9]. However, these variants appear only to have
enjoyed limited success, and primarily seem to have
been observed when the PMEN2 clone was present at a
comparatively high frequency relative to the use of
antibiotics in children selecting for resistance. Both the
count of clinical isolates and apparent change in Neτ in-
dicate a drop in the prevalence of clade IC1 beginning in
the mid- to late-1990s. Once the clone fell to a lower,
stable frequency in response to this change in prescrib-
ing, the pressure to revert to a sensitive phenotype is
likely to have been reduced. This may explain why no
further reversions to macrolide resistance were observed
from 1997 onwards. Alternatively, the limited success of
these variants may indicate that such mutations are only
adaptive over the short-term to atypically low antibiotic
use in a certain community [9].
By contrast, non-ICE ‘core’ sequences that caused anti-
biotic resistance were stable within clade IC1. For instance,
resistance to penicillins and co-trimoxazole was retained
despite the declining use of these drugs. This is inevitable
in the context of the clonal evolution of clade IC1; in the
absence of allelic replacement at dyr (encoding dihydrofo-
late reductase, the sequence of which determines suscepti-
bility to trimethoprim),f o l P(encoding dihydropteroate
synthase, the sequence of which determines susceptibility
to sulphonamides) or penicillin-binding protein genes, re-
version to the sensitive ancestral sequences was not pos-
sible. This is similar to the pattern of evolution observed in
serotype 3 isolates [37] and in contrast to the rapid import
of divergent sequence observed in PMEN1 [35] and
PMEN2 isolates from outside Iceland in this collection.
This absence of transformation largely appears to be the
consequence of the disruption of comYC by the insertion of
prophage ΦIC1, although it is not clear why the isolates
lacking this element still do not import sequence diversity
from other pneumococci. It may be that the prophage is
unstable only during disease or laboratory culturing, and
that, in fact, the prophage remained inserted in all carried
IC1 isolates. This failure to adapt to changing levels of anti-
biotic use in children through horizontal import of se-
quence may have played a part in the subsequent decline of
clade IC1 in Iceland after the mid-1990s.
Alternatively, the lack of antigenic diversification
resulting from the absence of recombination may have
contributed to the genotype’s fall in prevalence. The high
density of recombination events affecting the pspC locus
outside of the IC1 clade suggests a selective pressure to
alter such antigen-encoding genes. Therefore, the de-
crease in clade IC1’s frequency may be the consequence
of the resident population accumulating herd immunity
to the genotype [13]; this may be particularly acute in
Iceland, as the phylogeography of the lineage suggests
that only Reykjavík and the Southern Peninsular region
sustained the genotype long-term, potentially acting as a
source for the rest of the country. Declining transmission
within these communities may have resulted in an ensuing
fall in the rate of spread of the clade to other locations.
Furthermore, as the acquisition of a capsule differing
extensively from 6B seems unlikely within clade IC1, it
seems destined for elimination following the introduction
of polysaccharide conjugate vaccines (which induces im-
munity against both serotype 6A and 6B) in 2011 [8].
Conclusions
PMEN2 emerged in the 1960s, and a single transmis-
sion into Iceland in the late 1980s appears to have been
particularly successful despite its lack of sequence im-
port through homologous recombination. While this
limitation did not appear to inhibit the loss of anti-
biotic resistance found on mobile genetic elements, it
prevented modification of ‘core’ sequences associated
(See figure on previous page.)
Figure 5 Loss of resistance within clade IC1. (A) Loss of erythromycin and tetracycline resistance in group 3 isolates. (i) Plot of coverage
calculated by mapping sequence reads from group 3 isolate IC210 to the reference genome Tn916-type element, showing no coverage across
the transposon. This suggests it has been lost from the genome. (ii) Comparison of de novo assembly of isolate IC210 with the reference
sequence. The red bands between the two sequences indicate BLAT matches between sequences in the same orientation. The annotation of
the reference sequence is at the top; protein coding sequences (CDSs) are indicated by pink boxes, except for those that encode resistance
determinants, which are coloured blue. The brown boxes indicate the fragments of a CDS that is reformed by the apparent excision of the
transposon, as seen in the assembled sequence of isolate IC210 at the bottom of the diagram. (B) Loss of tetracycline resistance in group 2
isolates. The figure shows the structure of the tetM gene, including the positions of the promoter elements, leader peptide and ribosome binding
sites (RBS). A 58 bp deletion within the leader peptide, at the bases indicated by the shaded bar, appears to result in the inactivation of the gene.
(C) Loss of erythromycin resistance in group 4 isolates. The structure of the ermB gene is displayed as described for (B), with the position of the
sequence alteration leading to a frameshift mutation indicated by the shaded bar. (D) Loss of chloramphenicol resistance within some group 5
isolates through deletion of the cat chloramphenicol acetyltransferase gene on the Ωcat(pC194) element. (i) Plot of mapped sequence read
coverage and (ii) comparison of de novo assembly with the reference genome for group 5 isolate 0301 + 23540, displayed as in (A). BLAT,
BLAST-like alignment tool.
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contributed to its decline after the mid-1990s.
Methods
Selection of isolates for sequencing
Isolates with an MLST profile similar to that of ST90
were supplied by the sources listed in Additional file 1:
Table S1. In the case of the Icelandic representatives of
PMEN2, isolates were selected to produce a temporally
even sample over the course of the lineage’s spread
across the island when possible; these were supple-
mented by a set specifically chosen as exhibiting atypical
resistance profiles. Isolates were supplied by the same
set of clinical centres over the course of the study, but
the region from which they received samples was
reduced from the entire island pre-1995 to only the
Capitol and Southwestern regions post-1995. However,
these two districts accounted for the vast majority of
isolates across all years.
DNA sequencing and phylogenomics
DNA was sequenced as multiplexed libraries on the Illu-
mina Genome Analyzer II and HiSeq platforms, and the
raw data deposited in the European Nucleotide Archive
(ENA), as described by the read lengths and accession
codes in Additional file 1: Table S1. Serotype and se-
quence type were identified as described in [35] to check
the integrity of sample handling. Sequence reads were
mapped against the reference sequence of S. pneumoniae
670-6B (EMBL accession code: CP002176), an annotated
complete genome [54], using SMALT v0.6.4 as described
previously [38]. MGEs were identified in the reference gen-
ome through alignments with other complete pneumococ-
cal genomes. Polymorphisms were identified using criteria
defined in [34]. Samples showing signs of contamination,
based on the quality of de novo assemblies and signs of the
presence of multiple alleles in mapped sequence read data,
were discarded. Only samples with a mean coverage across
the entire reference genome above 25 fold and able to call
bases at >90% of reference positions, were used in the phy-
logenomic analysis. This generated a reference-based whole
genome alignment for phylogenetic and clustering analyses.
The identification of putative recombination events, and
generation of a phylogeny based on vertically-inherited
point mutations, was performed as described previously
[35]. This method identifies recombinations as regions of
t h eg e n o m ea f f e c t e db yh i g hd e n s i t i e so fb a s es u b s t i t u t i o n s
on individual branches of the phylogeny, which may reflect
homologous recombination or the movement of MGEs.
Therefore, to exclude horizontal sequence exchange likely
driven by the latter mechanism, homologous recombin-
ation events were defined as those occurring outside of the
annotated MGEs in the reference sequence.
Independently, the same whole genome alignment was
analysed using BRATNextGen [55], assuming three clus-
ters, using a learned value of alpha, a window size of one
kilobase and a significance threshold P value of 0.05 (as
calculated from 100 permutations).
Bayesian coalescent analyses
For the analysis of the PMEN2 clade, the topology of the
phylogeny was fixed as that of the relevant clade of the
overall phylogeny, in order to maintain consistency with
the prediction of recombinations. Analysis with Path-O-
Gen [56] revealed that this phylogeny displayed a signifi-
cant correlation between the root-to-tip distance of a
sample and its year of isolation [see Additional file 9:
Figure S8A]. The nucleotide alignment used was the
subset of positions at which base substitutions occurred
within the clade, with those substitutions introduced by
recombination excluded from the alignment, and the
dates of isolation used were the year, or range of years,
provided in Additional file 1: Table S1. Samples for
which no information regarding date of isolation was
available were each associated with a uniform prior dis-
tribution across the range of years of isolation of the rest
of the collection. Analysis with Bayesian evolutionary
analysis using sampling trees (BEAST) [57] used a gen-
eral time-reversible (GTR) substitution model with a
single rate category and a lognormal relaxed molecular
clock rate [58]. A Bayesian skyline plot was used as the
population demography prior [49]. Ten chains of 100
million states each were run; 50 million generations
were removed as burn-in and the remaining data com-
bined. All parameters were estimated with estimated
sample size (ESS) values above 200, with the exception
of the year of isolation of samples SPN11926 and
SN11927. However, joint marginal plots demonstrated
that neither of these parameters showed a significant
correlation with any of the values described in the text.
This model was compared to four others: a strict mo-
lecular clock, a random molecular clock, a lognormal re-
laxed clock with four rate categories and a lognormal
relaxed clock with a Hasegawa, Kishino and Yano (HKY)
substitution model. These analyses used the same input
data and were processed in the same way, and the same
parameters were estimated with ESS values above 200.
As assessed by Bayes factors [59], these alternative
models all fitted the data less well than that used for the
analysis described in the text [see Additional file 12:
Table S2]. In the case of the model using four rate cat-
egories the fit was only slightly worse as judged by Bayes
factors. However, the coefficient of variation in the ab-
sence of multiple rate categories (median estimate of
0.42; 95% credibility interval of 0.32 to 0.52) was not
found to provide evidence of extensive rate heterogen-
eity, hence this alternative model was rejected.
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was used, where available; otherwise, the 15th day of the
month of isolation was used as an approximation of the
day of isolation. Again, a significant correlation between
root-to-tip distance and day of isolation was observed
[see Additional file 9: Figure S8B]. The analysis was
otherwise conducted as described for the overall PMEN2
clade. The displayed tree and Bayesian skyline plot was
calculated using 10,000 trees (matched to the equivalent
number of states) derived through removing 50 million
generations from each of the ten 100 million generation
chains as burn-in, then resampling the remaining gener-
ations at a frequency of 1 per 50,000. All values were es-
timated with an ESS greater than 200. This model was
also compared to the same four alternative models as
described above [see Additional file 13: Table S3], and
once more the only other model to give a similarly good
fit to the data as the described analysis was that using a
lognormal relaxed molecular clock with four rate cat-
egories. However, the inclusion of the rate categories did
not significantly improve the fit, and the coefficient of
variation in the described analysis with a single rate cat-
egory had a median value of 0.33 (95% credibility inter-
val of 0.22 to 0.45), which suggested there was not
strong evidence of extensive rate heterogeneity. Hence,
the model with multiple rate categories was rejected on
the grounds of parsimony.
A discrete state phylogeographic model was used to
reconstruct the transmission of the IC1 clade across
Iceland [60]. When testing for significance of the ob-
served patterns through permutations, 100 versions of
the alignment were generated in which the locations
were randomly reassigned to isolates. The tree, se-
quences and dates of isolation were held constant. Each
permutation was analysed with BEAST using the same
model, but with a chain length of 10 million generations;
this was sufficient for the parameters of the discrete
states phylogeographic model to have converged. One
million of these were removed as burn-in and the
remaining trees (sampled at a frequency of 1 per 5,000
generations) used to determine the robustness of the
phylogeographic reconstruction.
Analysis of accessory genome distribution
For identification of novel accessory genome compo-
nents, Illumina sequence reads were assembled using
Velvet [61]. This was run iteratively to identify the k-
mer that gave the highest N50 value, while maintaining
an expected level of coverage above 20, as described previ-
ously [35]. Scaffolds were then generated using SSPACE2
[62], which were subsequently improved using the post as-
sembly genome improvement toolkit (PAGIT) pipeline
[63]. Sequence alignments were performed using BLAT
[64] with default settings and displayed using ACT [65].
The ICE displayed in Figure 2 have been submitted to
the ENA with the following accession codes: ICESp22664
(HG799489), ICESpDCC1902 (HG799491), ICESpDCC1738
(HG799492), ICESpDCC1524 (HG799493) and ICESp
6BST273 (HG799495). ICESpSPN8332, displayed in
Additional file 8: Figure S7, has been submitted to the
ENA with accession code HG799498. The prophage
sequence in Additional file 11: Figure S10 have been
submitted to the ENA with the following accession codes:
ϕDCC1738 (HG799497), ϕK13-0810 (HG799496) and
ϕIC1 (HG799490).
To ascertain the distribution of sequence reads across
the collection, reads were mapped to the accessory genome
component using BWA v0.7.3 [66]. The coverage plots
were then generated using Samtools [67]. Heatmaps were
generated using Biopython [68].
Additional files
Additional file 1: Table S1. Information regarding the source of
isolates, their phenotypic properties, and the accession codes for the raw
sequence data used in this analysis. Resistance to antibiotics is detailed
where the information is available; numerical values indicate a minimum
inhibitory concentration in milligrams per litre, whereas the outcome of
less precise phenotypic tests is indicated by the terms ‘sensitive’,
‘intermediate’ or ‘resistant’.
Additional file 2: Figure S1. Analysis of the whole genome alignment
using BRATNextGen. (A) Maximum likelihood phylogeny, as displayed in
Figure 1. (B) Simplified annotation of the reference genome as displayed
in Figure 1. (C) Results of the BRATNextGen analysis. This panel contains
one row for each isolate in the phylogeny, with a column for each base
in the reference genome. The background colour of each row represents
the recipient cluster to which the isolate belongs. Along each row,
changes of colour indicate putative recombinations; the colours indicate
which of the donor clusters is most likely to have been the origin of the
sequence. The overall pattern of recombination is similar to that
observed in Figure 1, with little evidence of the import of sequence by
clade IC1. As it is difficult to infer the directionality of exchange in some
cases using BRATNextGen, recombinations observed in Figure 1 are
sometimes reconstructed occurring in the same set of sequences, if both
methods agree on which alleles are ancestral and which derived, but in
other cases reconstructed as occurring in the complementary set of isolates, if
the two methods disagree on which allele replaces which. These expected
differences account for many of the superficial discrepancies between this
analysis and that in Figure 1.
Additional file 3: Figure S2. Distribution of homologous recombination
lengths. Histograms showing the lengths of recombinations outside of MGEs
for the entire collection (A) or just those recombinations within the PMEN2
clade (B). The red curves represent the fitting of exponential distributions, with
the rate parameters 1.14 × 10
−4 bp
−1 (95% confidence interval, 1.04 × 10
−4 to
1.26 × 10
−4 bp
−1) and 1.25 × 10
−4 bp
−1 (95% confidence interval, 1.11 × 10
−4
to 1.42 × 10
−4 bp
−1), respectively.
Additional file 4: Figure S3. Detail of the maximum likelihood
phylogeny. The tree is coloured as in Figure 1, and the PMEN2 and
PMEN22 clades labeled. All isolate names, as listed in Additional file 1:
Table S1, are annotated on leaf nodes, while internal nodes are marked
with the level of inferred support from 100 bootstrap replicates.
Additional file 5: Figure S4. Distribution of Tn916-associated
sequences. (A) Maximum likelihood phylogeny, as displayed in Figure 1.
(B) Sequence of the Tn916-type element found in PMEN1, concatenated
to the three macrolide resistance elements found in that lineage: the
Omega, Tn917 and mega cassettes. (C) Heatmap showing the mapping
of Illumina reads to the sequences; blue indicates an absence of
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maximum level capped at a depth of 10 fold coverage. Each row
corresponds to one of the leaf nodes in the tree.
Additional file 6: Figure S5. Distribution of Tn5253-type ICEs. (A)
Maximum likelihood phylogeny, as displayed in Figure 1. (B) Distribution
of ICESp6BST90. The annotated sequence of ICESp6BST90 is displayed
across the top of the column, and a heatmap used to indicate the
distribution of the ICE sequences across the collection, as described in
Additional file 5: Figure S4. This demonstrates that ICESp6BST90 is found
throughout PMEN2, although with sporadic deletion of the Ωcat
(pC194)-like element. (C) Distribution of ICESp6BST273, displayed as
described in (B). In this case, the full length element appears to be
stable across the PMEN22 clade only.
Additional file 7: Figure S6. Chloramphenicol resistance cassettes. The
Ωcat(pC194) cassette previously identified as a mobile element in Tn5253
is shown compared to the very similar element found within the
PMEN22 isolate SPN13633 and the more divergent gene cluster present
in ICESp6BST90. Red bands indicate regions of sequence similarity as
identified by BLAT. The linearized plasmid pC194 is conserved in all the
elements, as are the flanking sequences at the edges that include the
85 bp imperfect direct repeats.
Additional file 8: Figure S7. Deletion of a section of Tn916-type ICE.
Alignment of the Tn916-type component of ICESp6BST90 with the Tn916-type
components of isolates SPN8332 (from this study), 11930 and 9409 (from the
PMEN1 lineage). Red bands indicate regions of sequence similarity identified
by BLAT. ICESpSPN8332 has been modified such that the majority of the
Tn916-type component, including the tetM tetracycline resistance gene, has
been replaced with an Omega cassette-type sequence, encoding an aph3’
aminoglycoside phosphotransferase, and a Tn917-type sequence, encoding an
ermB rRNA methylase. Each copy of the ermB gene is highlighted by an or-
ange box. The generation of ICESpSPN8332 is likely to be the consequence of
Omega and Tn917 macrolide resistance cassettes both inserting into a Tn916-
type element, as can be seen in ICESpn11930 (although in this case, only a
fragment of the Omega cassette remains; the full version is evident in
ICESpn9409). This results in two ermB genes arranged in tandem, between
which an intragenomic recombination may occur that eliminates the interven-
ing sequence. This results in the isolate being sensitive to tetracycline but re-
sistant to aminoglycosides and macrolides.
Additional file 9: Figure S8. Root-to-tip distance plots. (A) For each
isolate within the PMEN2 clade associated with a precise year of isolation,
this value was plotted against the distance of the corresponding sample
from the root of the clade. This revealed a significant positive correlation
(n=168, R
2 =0.63, P <2.2 × 10
−16) that provides evidence for a molecular
clock signal in the data. (B) This shows the equivalent plot for the IC1
clade, where the date of isolation is plotted in terms of days, rather than
years, again providing evidence of a molecular clock (n= 112, R
2 = 0.56,
P <2.2 × 10
−16).
Additional file 10: Figure S9. Distribution of prophage ΦIC1 sequence.
(A) Maximum likelihood phylogeny, as displayed in Figure 1. (B)
Annotation of prophage ΦIC1. The pink boxes represent CDSs, with their
vertical position indicating whether they are encoded on the forward or
reverse strand of the genome. The functional modules of the prophage
are marked by the black bars across the top of the figure. The orange
and brown bars indicate the extent of the scaffolds on which the two
fragments of the phage are present, with the junction between them
indicating a break in the draft assembly. (C) Heatmap showing the
mapping of Illumina reads to the prophage sequence; blue indicates an
absence of mapping, while red indicates high levels of mapping, with
the maximum coverage level capped at 25 fold. Each row corresponds
to one of the samples in the tree. Isolates of clade IC1 tended to show
consistent mapping across the entire sequence if the prophage is
present in their genome; many other samples only show mapping to
parts of the sequence owing to the presence of related prophage.
Mapping to the lysogeny module, which contains the integrase that
determines the insertion site of the virus, is indicative of prophage
inserted into the comYC gene.
Additional file 11: Figure S10. Prophage inserting into comYC.A s
isolates were frequently polylysogenic, many prophage were difficult
to assemble. These four examples represent the most complete
assemblies of prophage inserting into the comYC gene. The top
sequence is taken from the complete reference genome; prophage
ΦIC1 spans two scaffolds, with the assembly break between them
indicated by the vertical dashed line; the sequences of ΦDCC1738
and ΦK13-0810 are present on a single contig, but the lytic amidase is
truncated by an assembly break in both. The pink boxes mark CDSs,
with their vertical position indicating whether they are encoded on
the forward or reverse strand of the genome. The functional modules
of the prophage are marked by the black bars across the top of the
figure. The red bands between sequences indicate BLAT matches, with
the intensity of the colour representing the strength of the match.
It can be seen that the integrase within the lysogeny module is conserved,
reflecting the common insertion site shared by the elements.
Additional file 12: Table S2. Comparison of different evolutionary
models fitted to the PMEN2 clade using BEAST. Five different models
are compared using log10 Bayes factors. Positive values of Bayes factors
indicates a comparatively better fit of the model described in the row to
the data relative to the model indicated by the column heading.
Additional file 13: Table S3. Comparison of different evolutionary
models fitted to the IC1 clade using BEAST. Five different models are
compared using log10 Bayes factors. Positive values of Bayes factors
indicates a comparatively better fit of the model described in the row
to the data relative to the model indicated by the column heading.
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